Dow Down0.02% Nasdaq Up0.38%

Neurocrine Biosciences Inc. (NBIX)

-NMS
16.37 Up 0.38(2.38%) 11:26AM EDT - Nasdaq Real Time Price
Cash FlowGet Cash Flow for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingDec 31, 2013Dec 31, 2012Dec 31, 2011
Net Income (46,090) 5,025   37,571  
Operating Activities, Cash Flows Provided By or Used In
Depreciation3,514  3,792  3,035  
Adjustments To Net Income872  (30,440)(36,788)
Changes In Accounts Receivables13,528  (12,878)2,813  
Changes In Liabilities(1,431)(793)(7,329)
Changes In Inventories -   -   -  
Changes In Other Operating Activities -   -   -  
Total Cash Flow From Operating Activities (29,607) (35,294) (698)
Investing Activities, Cash Flows Provided By or Used In
Capital Expenditures(545)(971)(750)
Investments5,953  (33,793)(4,823)
Other Cash flows from Investing Activities(68)3  2,041  
Total Cash Flows From Investing Activities 5,340   (34,761) (3,532)
Financing Activities, Cash Flows Provided By or Used In
Dividends Paid -   -   -  
Sale Purchase of Stock5,302  83,702  286  
Net Borrowings -   -   -  
Other Cash Flows from Financing Activities -   -   -  
Total Cash Flows From Financing Activities 5,302   83,702   286  
Effect Of Exchange Rate Changes -   -   -  
Change In Cash and Cash Equivalents (18,965) 13,647   (3,944)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.